- Home
- ASAN vs VKTX Comparison
ASAN vs VKTX Comparison
Compare ASAN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASAN
- VKTX
- Stock Information
- Founded
- ASAN 2008
- VKTX 2012
- Country
- ASAN United States
- VKTX United States
- Employees
- ASAN N/A
- VKTX 49
- Industry
- ASAN Retail: Computer Software & Peripheral Equipment
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASAN Technology
- VKTX Health Care
- Exchange
- ASAN Nasdaq
- VKTX Nasdaq
- Market Cap
- ASAN 3.3B
- VKTX 2.6B
- IPO Year
- ASAN 2020
- VKTX 2015
- Fundamental
- Price
- ASAN $14.38
- VKTX $26.04
- Analyst Decision
- ASAN Hold
- VKTX Strong Buy
- Analyst Count
- ASAN 14
- VKTX 12
- Target Price
- ASAN $17.04
- VKTX $87.50
- AVG Volume (30 Days)
- ASAN 4.4M
- VKTX 6.0M
- Earning Date
- ASAN 09-03-2025
- VKTX 10-22-2025
- Dividend Yield
- ASAN N/A
- VKTX N/A
- EPS Growth
- ASAN N/A
- VKTX N/A
- EPS
- ASAN N/A
- VKTX N/A
- Revenue
- ASAN $756,419,000.00
- VKTX N/A
- Revenue This Year
- ASAN $10.81
- VKTX N/A
- Revenue Next Year
- ASAN $8.50
- VKTX N/A
- P/E Ratio
- ASAN N/A
- VKTX N/A
- Revenue Growth
- ASAN 9.74
- VKTX N/A
- 52 Week Low
- ASAN $11.08
- VKTX $18.92
- 52 Week High
- ASAN $27.77
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- ASAN 54.48
- VKTX 45.24
- Support Level
- ASAN $13.11
- VKTX $22.96
- Resistance Level
- ASAN $14.02
- VKTX $26.50
- Average True Range (ATR)
- ASAN 0.68
- VKTX 1.31
- MACD
- ASAN 0.03
- VKTX 0.01
- Stochastic Oscillator
- ASAN 48.94
- VKTX 58.12
About ASAN Asana Inc.
Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.